Consensus Review of Perioperative Immune Modulation for Endovascular Thrombectomy Following Ischemic Stroke
- 1 May 2026
- journal article
- review article
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (5) , 1450-1463
Abstract
Ischemic stroke is a major global health burden, leading to considerable mortality and long-term disability. Endovascular thrombectomy and mechanical recanalization have revolutionized acute stroke care. Nonetheless, many patients experience poor long-term neurological outcomes, which are often attributed to the no-reflow phenomenon and activation of inflammatory cascades. The perioperative period of endovascular thrombectomy, managed under either general anesthesia or conscious sedation, represents a critical window where anesthetic strategies may influence recovery through hemodynamic control and possibly immune modulation. This consensus review was generated by an international multidisciplinary expert group and synthesizes preclinical and clinical evidence to evaluate the promise of various immunomodulatory strategies for improving functional outcomes in patients with ischemic stroke following endovascular thrombectomy. Our goal is to provide a foundational reference for future research and development of novel perioperative immune therapies for patients with endovascular thrombectomy.Keywords
This publication has 102 references indexed in Scilit:
- Methylprednisolone as Adjunct to Endovascular Thrombectomy for Large-Vessel Occlusion StrokeJAMA, 2024
- Allogeneic Stem Cell Therapy for Acute Ischemic StrokeJAMA Neurology, 2024
- Thromboinflammatory challenges in stroke pathophysiologySeminars in Immunopathology, 2023
- A comparative study of different doses of bone marrow-derived mesenchymal stem cells improve post-stroke neurological outcomes via intravenous transplantationBrain Research, 2022
- Filling the gaps on stroke research: Focus on inflammation and immunityBrain, Behavior, and Immunity, 2021
- Neutrophils Obstructing Brain Capillaries Are a Major Cause of No-Reflow in Ischemic StrokeCell Reports, 2020
- FasL-PDPK1 Pathway Promotes the Cytotoxicity of CD8+ T Cells During Ischemic StrokeTranslational Stroke Research, 2020
- Endovascular Thrombectomy as a Means to Improve Survival in Acute Ischemic StrokeJAMA Neurology, 2019
- Differential effects of sympathetic nervous system and hypothalamic–pituitary–adrenal axis on systemic immune cells after severe experimental strokeBrain, Behavior, and Immunity, 2014
- Improvement of functional recovery by chronic metformin treatment is associated with enhanced alternative activation of microglia/macrophages and increased angiogenesis and neurogenesis following experimental strokeBrain, Behavior, and Immunity, 2014